Search research articles
Contact Us
Filters
Showing results (101-110 of 115) with videos related to
Page
of 12
Sort By:
Biomolecules
|
July 8, 2016
Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents
Bryan Oronsky, Jan Scicinski, Michelle M Kim, et al.
Cancers
|
June 28, 2023
A Local and Abscopal Effect Observed with Liposomal Encapsulation of Intratumorally Injected Oncolytic Adenoviral Therapy
Tao Dong, Jaimin R Shah, Abraham T Phung, et al.
Breast Cancer Research : BCR
|
September 10, 2024
CAR expression in invasive breast carcinoma and its effect on adenovirus transduction efficiency
Abraham T Phung, Jaimin R Shah, Tao Dong, et al.
Bioengineering (Basel, Switzerland)
|
November 10, 2022
Development of Adenovirus Containing Liposomes Produced by Extrusion vs. Homogenization: A Comparison for Scale-Up Purposes
Jaimin R Shah, Tao Dong, Abraham T Phung, et al.
ACS Biomaterials Science & Engineering
|
November 17, 2022
Full Remission of CAR-Deficient Tumors by DOTAP-Folate Liposome Encapsulation of Adenovirus
Ching-Hsin Huang, Tao Dong, Abraham T Phung, et al.
Oncology Research and Treatment
|
November 18, 2016
Conversion of Platinum-Etoposide-Resistant to Sensitive SCLC after Treatment with the Epi-Immunotherapeutic RRx-001: A Case Report
Christina Brzezniak, Bryan Oronsky, Jan Scicinski, et al.
Future Oncology (London, England)
|
September 12, 2019
REPLATINUM Phase III randomized study: RRx-001 + platinum doublet versus platinum doublet in third-line small cell lung cancer
Bryan Oronsky, Tony R Reid, Christopher Larson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 16, 2023
PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy
Marcelo Bonomi, Dukagjin M Blakaj, Rafi Kabarriti, et al.
Clinical Medicine Insights. Oncology
|
November 15, 2016
A Partial Response to Reintroduced Chemotherapy in a Resistant Small Cell Lung Cancer Patient After Priming with RRx-001
Bryan Oronsky, Scott Caroen, Karen Zeman, et al.
Future Oncology (London, England)
|
August 11, 2022
BETA PRIME: Phase I study of AdAPT-001 as monotherapy and combined with a checkpoint inhibitor in superficially accessible, treatment-refractory solid tumors
Santosh Kesari, Alberto Bessudo, Brian R Gastman, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 115) with videos related to
Sort By:
Page
of 12
Biomolecules
|
July 8, 2016
Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents
Bryan Oronsky, Jan Scicinski, Michelle M Kim, et al.
Cancers
|
June 28, 2023
A Local and Abscopal Effect Observed with Liposomal Encapsulation of Intratumorally Injected Oncolytic Adenoviral Therapy
Tao Dong, Jaimin R Shah, Abraham T Phung, et al.
Breast Cancer Research : BCR
|
September 10, 2024
CAR expression in invasive breast carcinoma and its effect on adenovirus transduction efficiency
Abraham T Phung, Jaimin R Shah, Tao Dong, et al.
Bioengineering (Basel, Switzerland)
|
November 10, 2022
Development of Adenovirus Containing Liposomes Produced by Extrusion vs. Homogenization: A Comparison for Scale-Up Purposes
Jaimin R Shah, Tao Dong, Abraham T Phung, et al.
ACS Biomaterials Science & Engineering
|
November 17, 2022
Full Remission of CAR-Deficient Tumors by DOTAP-Folate Liposome Encapsulation of Adenovirus
Ching-Hsin Huang, Tao Dong, Abraham T Phung, et al.
Oncology Research and Treatment
|
November 18, 2016
Conversion of Platinum-Etoposide-Resistant to Sensitive SCLC after Treatment with the Epi-Immunotherapeutic RRx-001: A Case Report
Christina Brzezniak, Bryan Oronsky, Jan Scicinski, et al.
Future Oncology (London, England)
|
September 12, 2019
REPLATINUM Phase III randomized study: RRx-001 + platinum doublet versus platinum doublet in third-line small cell lung cancer
Bryan Oronsky, Tony R Reid, Christopher Larson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 16, 2023
PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy
Marcelo Bonomi, Dukagjin M Blakaj, Rafi Kabarriti, et al.
Clinical Medicine Insights. Oncology
|
November 15, 2016
A Partial Response to Reintroduced Chemotherapy in a Resistant Small Cell Lung Cancer Patient After Priming with RRx-001
Bryan Oronsky, Scott Caroen, Karen Zeman, et al.
Future Oncology (London, England)
|
August 11, 2022
BETA PRIME: Phase I study of AdAPT-001 as monotherapy and combined with a checkpoint inhibitor in superficially accessible, treatment-refractory solid tumors
Santosh Kesari, Alberto Bessudo, Brian R Gastman, et al.
Page
of 12